Aspen Group, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Narrative (Details)

Stockholders' Equity - Narrative (Details)								3 Months Ended
Stockholders' Equity - Narrative (Details)	Apr. 22, 2022 USD ($) $ / shares shares	Aug. 31, 2021 USD ($) $ / shares shares	Aug. 16, 2021 USD ($) $ / shares shares	Aug. 12, 2021 USD ($) $ / shares shares	Jul. 21, 2021 USD ($) $ / shares shares	Mar. 08, 2020 shares	Feb. 04, 2020 $ / shares	Jul. 31, 2022 USD ($) plan shares	Jul. 31, 2021 USD ($) shares	Jul. 06, 2022 shares	Jul. 05, 2022 shares	Apr. 30, 2022 USD ($) shares	Apr. 25, 2022 $ / shares shares	Dec. 22, 2021 shares	Dec. 30, 2020 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock-based incentive plans \| plan								2
Transfer of unused awards (in shares)						129,009
Common stock, shares authorized (in shares)								60,000,000		60,000,000	40,000,000	60,000,000
Preferred stock, shares authorized (in shares)								1,000,000				1,000,000
Preferred stock outstanding (in shares)								0				0
Preferred stock issued (in shares)								0				0
Share price (in dollars per share) \| $ / shares							$ 9.49
Deferred financing costs \| $								$ 302,834				$ 369,902
Unrecognized compensation costs \| $								$ 130
Treasury stock (in shares)								155,486				155,486
Treasury stock, value \| $								$ 1,817,414				$ 1,817,414
Revolving Credit Facility \| Two Thousand Twenty Two Revolving Credit Facility
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Deferred financing costs \| $								$ 112,100
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested shares of restricted common stock outstanding (in shares)								0
Total unrecognized compensation expense \| $								$ 0
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested shares of restricted common stock outstanding (in shares)								742,755				929,928
Total unrecognized compensation expense \| $								$ 2,635,885
Shares granted (in shares)								0
Grant date fair value \| $				$ 1,000,000
Share price (in dollars per share) \| $ / shares				$ 6.48
Weighted average recognition period								1 year 4 months 13 days
RSUs \| Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested shares of restricted common stock outstanding (in shares)								162,500
Weighted average recognition period							4 years
Minimum closing price of common stock (in dollars per share) \| $ / shares							$ 12
Consecutive trading days							20 days
RSUs \| Chief Financial Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)			125,000
Grant date fair value \| $			$ 725,000
Share price (in dollars per share) \| $ / shares			$ 5.80
RSUs \| Chief Academic Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)				80,000
RSUs \| Chief Operating Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)				80,000
RSUs \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)					125,000
Grant date fair value \| $					$ 873,750
Share price (in dollars per share) \| $ / shares					$ 6.99
Amortization expense \| $								$ 242,708	$ 72,813
Amortization period of expense					3 years
RSUs \| Chief Nursing Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amortization expense \| $								34,150	$ 112,155
Warrant
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of warrant		5 years											5 years
Warrant \| Intercreditor Agreement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities called by warrants or rights (in shares)	100,000
Exercise price of warrants (in dollars per share) \| $ / shares	$ 1.00
Fair value of warrants outstanding \| $	$ 118,000
Deferred financing costs \| $								112,100				$ 118,000
Loss on asset disposition \| $								5,900
Exercise period of warrant	5 years
Warrant \| Revolving Credit Facility \| Two Thousand Twenty Two Revolving Credit Facility
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities called by warrants or rights (in shares)													100,000
Exercise price of warrants (in dollars per share) \| $ / shares													$ 1.00
Warrant \| Revolving Credit Facility \| Credit Facility Agreement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of warrant		14 months
Fair value of warrants outstanding \| $		$ 137,500
Warrant \| Leon and Toby Cooperman Family Foundation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities called by warrants or rights (in shares)		50,000
Exercise price of warrants (in dollars per share) \| $ / shares		$ 5.85
Loss on asset disposition \| $								11,167
Exercise period of warrant		5 years
Warrant \| Former Board of Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amortization expense \| $								$ 7,000
Number of securities called by warrants or rights (in shares)					25,000
Vesting period of warrant					3 years
Exercise price of warrants (in dollars per share) \| $ / shares					$ 6.99
Fair value of warrants outstanding \| $					$ 84,000
Exercise period of warrant					5 years
Stock Incentive Plan and Stock Option Grants to Employees and Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)								0	0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average recognition period								5 months 1 day
Maximum \| Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized (in shares)								1,000,000
Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares remaining for future issuance (in shares)								1,050,591				812,763
2018 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)														2,350,000	1,600,000
2018 Equity Incentive Plan \| RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average recognition period								3 years
Amortization expense \| $								$ 146,817